First Meeting of Technical Guidelines Development Group (TDG) on Pharmacotherapy of Opioid Dependence
1-4 November 2005 - Geneva, Switzerland
Scope and Purpose
In response to the resolution of the UN Economic and Social Council 2004/40, inviting WHO "…to develop and publish minimum requirements and international guidelines on psychosocially assisted pharmacological treatment of persons dependent on opioids, taking into account regional initiatives in this field", the Management of Substance Abuse Team under the WHO Department of Mental Health and Substance Abuse, has started the process of developing Guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids, in collaboration with UNODC. According to the recommended process for developing WHO practice guidelines, a Technical Guideline Development Group (TDG) was established that consists of experts from different relevant areas of knowledge and expertise representing different WHO regions.
The main objectives of the first meeting of TDG are the following:
- define the overall structure and content of the guidelines and specific issues that have to be addressed;
- review available evidence on efficacy, safety and cost-effectiveness of pharmacological and psychosocial interventions;
- review available information on minimum health system and service requirements for provision of quality treatment of opioid dependence, including in resource poor settings; and
- identify specific areas and issues for further critical review or expert consultations.
Background documents
-
ECOSOC Resolution 2004/40 on Guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids
pdf, 24kb -
Guidelines for WHO Guidelines (WHO/EIP/GPE/EQC/2003.1)
pdf, 230kb -
An Overview of Cochrane Systematic Reviews of Pharmacological and Psychosocial Treatment of Opioid Dependence
pdf, 790kb -
Opium abuse and its management: global scenario
pdf, 98kb -
The practices and context of pharmacotherapy of opioid dependence in South-East Asia and Western Pacific Regions
pdf, 320kb -
The practices and context of pharmacotherapy of opioid dependence in Central and Eastern Europe
pdf, 1.04Mb -
WHO/UNODC/UNAIDS position paper on Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention
pdf, 499kb -
Proposal for the inclusion of Buprenorphine in the WHO Model List of Essential Medicines
pdf, 287kb